Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Fickert

Showing results (121-130 of 163) with videos related to

Pageof 17
Sort By:
Cells|October 23, 2021
Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid LipaseVinay Sachdev, Madalina Duta-Mare, Melanie Korbelius, et al.
Gastroenterology|August 9, 2005
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humansHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
Toxins|January 20, 2022
Acute Liver Failure after Ingestion of Fried Rice Balls: A Case Series of <i>Bacillus cereus</i> Food PoisoningsNikolaus Schreiber, Gerald Hackl, Alexander C Reisinger, et al.
Journal of Hepatology|December 5, 2012
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitisMarco Marzioni, Stefania Saccomanno, Laura Agostinelli, et al.
Nutrients|June 27, 2020
Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated CirrhosisAngela Horvath, Marija Durdevic, Bettina Leber, et al.
Gastroenterology|September 2, 2003
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated miceMartin Wagner, Peter Fickert, Gernot Zollner, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
World Journal of Hepatology|March 23, 2016
Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse modelFlorian P Reiter, Ralf Wimmer, Lena Wottke, et al.
BMC Nephrology|December 3, 2015
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosisElisabeth Krones, Peter Fickert, Sabine Zitta, et al.
Scientific Reports|August 3, 2017
NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patientsChristoph Jüngst, Vanessa Stadlbauer, Matthias C Reichert, et al.
Pageof 17

Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Cells|October 23, 2021
Impaired Bile Acid Metabolism and Gut Dysbiosis in Mice Lacking Lysosomal Acid LipaseVinay Sachdev, Madalina Duta-Mare, Melanie Korbelius, et al.
Gastroenterology|August 9, 2005
Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humansHanns-Ulrich Marschall, Martin Wagner, Gernot Zollner, et al.
Toxins|January 20, 2022
Acute Liver Failure after Ingestion of Fried Rice Balls: A Case Series of <i>Bacillus cereus</i> Food PoisoningsNikolaus Schreiber, Gerald Hackl, Alexander C Reisinger, et al.
Journal of Hepatology|December 5, 2012
PDX-1/Hes-1 interactions determine cholangiocyte proliferative response to injury in rodents: possible implications for sclerosing cholangitisMarco Marzioni, Stefania Saccomanno, Laura Agostinelli, et al.
Nutrients|June 27, 2020
Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated CirrhosisAngela Horvath, Marija Durdevic, Bettina Leber, et al.
Gastroenterology|September 2, 2003
Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated miceMartin Wagner, Peter Fickert, Gernot Zollner, et al.
Digestive Diseases (Basel, Switzerland)|June 6, 2015
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic DisordersMichael Trauner, Emina Halilbasic, Thierry Claudel, et al.
World Journal of Hepatology|March 23, 2016
Role of interleukin-1 and its antagonism of hepatic stellate cell proliferation and liver fibrosis in the Abcb4(-/-) mouse modelFlorian P Reiter, Ralf Wimmer, Lena Wottke, et al.
BMC Nephrology|December 3, 2015
The chronic kidney disease epidemiology collaboration equation combining creatinine and cystatin C accurately assesses renal function in patients with cirrhosisElisabeth Krones, Peter Fickert, Sabine Zitta, et al.
Scientific Reports|August 3, 2017
NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patientsChristoph Jüngst, Vanessa Stadlbauer, Matthias C Reichert, et al.
Pageof 17